Water Seal Chamber
The water seal allows air to leave the pleural space while preventing atmospheric air from moving back toward the patient.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Size, Share & Industry Analysis, By Type (Wet Suction, Dry Suction), By Application (Ambulatory, Emergency, Other), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Thoracic & Pulmonary Centers), By Chamber Configuration (Single Collection Chamber, Dual / Multi-Chamber Systems, Autotransfusion-Capable Systems), By Patient Group (Adult, Pediatric), and Regional Forecast, 2026-2034
The global water seal chest drainage unit market was valued at USD 657.0 million in 2025 and is estimated at USD 683.7 million in 2026. The market is projected to reach USD 939.9 million by 2034, representing a 4.1% CAGR during 2026–2034.
Water seal chest drainage units are disposable or reusable collection systems used with thoracic catheters to evacuate air, blood or fluid from the pleural space while preventing atmospheric air from re-entering the chest. Systems are used after cardiothoracic surgery, for pneumothorax and hemothorax, and during emergency or ambulatory thoracic care.
The core product architecture combines a collection chamber with a water-seal chamber and, in many systems, wet or dry suction regulation. Getinge’s Atrium Oasis is a dry-suction water-seal system with adjustable suction from -10 to -40 cmH - O, a visible air-leak monitor and pressure-relief features. Teleflex Pleur-evac offers dry-suction/wet-seal and wet-suction/wet-seal configurations, illustrating the continuing coexistence of both suction technologies.
Regulatory and labeling discipline remains important because correct setup and patient-tube connections are essential to drainage performance. FDA records list Atrium and Pleur-evac chest drainage systems as regulated devices, while a 2026 field safety notice for Cardinal Health chest drainage units clarified the intended adult patient population for affected products. These developments reinforce the importance of clear IFUs, visible drainage assessment and device-specific training.
Source: FDA Atrium chest-drain clearance; Getinge Atrium Oasis; Getinge chest-drain education; Teleflex Pleur-evac; FDA Pleur-evac device listing; 2026 Cardinal Health field safety notice.
The study defines the global water seal chest drainage unit market market by the equipment, application, end-user and technology boundaries listed below. The scope is structured to keep market sizing consistent with the commercial systems and services included in the syndicated study.
| Report Attribute | Coverage |
|---|---|
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026–2034 |
| Market Measurement | Revenue, USD million |
| By Type | Wet Suction; Dry Suction |
| By Application | Ambulatory; Emergency; Other |
| By End User | Hospitals; Ambulatory Surgical Centers; Specialty Thoracic & Pulmonary Centers |
| By Chamber Configuration | Single Collection Chamber; Dual / Multi-Chamber Systems; Autotransfusion-Capable Systems |
| By Patient Group | Adult; Pediatric |
| By Region | North America; Europe; Asia-Pacific; Latin America; Middle East & Africa |
| Selected Countries | United States; Canada; Germany; United Kingdom; France; Italy; China; Japan; South Korea; India; Australia; Brazil; Saudi Arabia; UAE and other relevant markets |
| Key Market Players | Getinge / Atrium Medical; Teleflex / Pleur-evac; Cardinal Health; Redax; Armstrong Medical; Alleva Medical; Shinva Ande Healthcare Apparatus; Ningbo Xinwell Medical Technology; Pacific Hospital Supply |
The market includes water-seal chest drainage units, wet- and dry-suction drainage systems, collection chambers and integrated chest-drain products used to evacuate air or fluid from the pleural space.
Thoracic catheters sold separately, digital pleural-drain monitors without a water-seal collection function, vacuum wound systems and unrelated surgical drainage products are outside the core revenue boundary.
Chest drains are routinely used after many cardiac and thoracic procedures to remove blood, air and pleural fluid and support lung re-expansion.
Getinge Oasis provides fingertip suction adjustment from -10 to -40 cmH - O, allowing clinicians to set drainage pressure without relying on water-column bubbling for suction control.
Water-seal chambers allow clinicians to observe bubbling or air-leak patterns, making chamber visibility and graduated leak monitoring important product features.
Disposable drainage units reduce reprocessing burden and are standard across many hospitals, creating recurring procedure-linked consumption.
Recent field actions and updated IFUs show that tubing connection, target population and setup instructions remain important to safe operation.
Source: Getinge Oasis; FDA Atrium; NHS notice.
Dry regulators simplify suction setting, reduce noise and remove the need to maintain a suction-control water column.
Smaller drainage systems and mobile configurations support earlier mobility and selected outpatient or step-down care.
Manufacturers emphasize larger graphics, visible leak meters and simplified chamber layouts to help clinicians assess drainage quickly.
Modern systems include high- and low-pressure protection and design features that reduce fluid migration between chambers.
Getinge and Teleflex maintain extensive training resources, setup posters and troubleshooting guides because safe use depends heavily on correct bedside configuration.
Source: Getinge Oasis; Getinge education; Teleflex.
Water-seal chest drainage combines one-way pleural protection, fluid collection and optional regulated suction in a closed bedside system.
The water seal allows air to leave the pleural space while preventing atmospheric air from moving back toward the patient.
Wet systems use water-column control, while dry systems use mechanical regulation to set suction pressure.
Transparent calibrated chambers allow volume and color assessment of blood or pleural fluid.
Visible leak indicators and pressure-relief valves help clinicians monitor system function and patient status.
Source: Getinge Oasis; Teleflex; Redax.
By type, the market is segmented into wet-suction and dry-suction water-seal chest drainage units. Dry suction is the leading segment because mechanical suction control simplifies setup and reduces dependence on water-column maintenance.
Wet-suction systems use a water column to regulate suction and remain familiar in hospitals with long-standing chest-drain protocols.
Dry-suction systems use mechanical control, support quieter operation and allow direct suction setting without a bubbling control chamber.
Dry-suction systems should remain the leading segment, while wet suction retains a meaningful installed base because of clinician familiarity and lower complexity.
By application, the market is segmented into ambulatory, emergency and other uses. Emergency and acute inpatient use represents the largest high-acuity application, while ambulatory drainage is a growth area.
Portable drainage supports patient mobility, selected outpatient care and step-down recovery.
Trauma, spontaneous pneumothorax and acute pleural collections require immediate chest drainage in emergency and critical-care settings.
Other uses include postoperative cardiothoracic care, pleural effusion management and selected pulmonary procedures.
Emergency and postoperative use will remain the largest clinical demand base, while ambulatory drainage should gain share through mobility-focused care.
By end user, the market is segmented into hospitals, ambulatory surgical centers and specialty thoracic or pulmonary centers. Hospitals are the leading end user.
Hospitals manage cardiothoracic surgery, trauma, critical care and complex pleural disease and therefore account for the largest drainage-unit consumption.
ASCs use chest drainage in selected thoracic and postoperative cases where patient selection permits.
Dedicated centers manage recurrent pleural disease, chest-tube follow-up and complex thoracic care.
Hospitals will remain the dominant end user because severe pleural disease and thoracic surgery are concentrated in acute-care settings.
By chamber configuration, the market is segmented into single collection chamber, dual or multi-chamber systems, and autotransfusion-capable systems. Single collection systems lead routine use because they balance simplicity and capacity.
Single-chamber systems are common in adult and pediatric bedside drainage and simplify setup and visual assessment.
Multi-chamber systems separate collection, seal and suction functions and can support higher-volume or specialized workflows.
ATS configurations can support blood recovery in selected surgical cases where reinfusion protocols are used.
Single collection systems should remain the largest configuration, while multi-chamber and autotransfusion designs retain specialist value.
By patient group, the market is segmented into adult and pediatric use. Adults represent the leading segment because most cardiothoracic surgery, pleural disease and trauma volume occurs in adult populations.
Adult drainage systems account for the largest procedure volume across surgery, emergency care and pulmonary disease.
Pediatric drainage requires smaller tubing, lower-volume collection and age-appropriate setup, creating a distinct specialized segment.
Adults will remain the dominant patient group, while pediatric systems require dedicated product design and careful labeling.
Regional demand reflects cardiothoracic procedure volume, trauma systems and hospital infrastructure. North America is the largest market, while Asia-Pacific offers the strongest long-term volume growth.
The United States and Canada have high thoracic-surgery intensity, trauma networks and a mature installed base of disposable water-seal systems.
Europe combines strong cardiothoracic care with established suppliers including Getinge, Redax and regional manufacturers.
China, Japan, South Korea, India and Australia are expanding hospital capacity, thoracic surgery and critical care.
Brazil and Mexico lead regional demand, with procurement influenced by disposable-device budgets.
Gulf tertiary hospitals support premium products, while broader adoption follows critical-care infrastructure growth.
Source: FDA Atrium; Getinge; FDA Teleflex.
Chest drainage units are regulated medical devices whose performance depends on correct setup, secure tubing connections, pressure control and visible assessment of drainage.
| Framework / Event | Requirement or Development | Commercial Relevance |
|---|---|---|
| FDA device oversight | Atrium ATS chest drains and Teleflex Pleur-evac systems have active U.S. device records. | Confirms established regulated product classes. |
| Pressure control | Modern systems provide regulated suction and pressure-relief features. | Supports safer closed drainage. |
| 2026 labeling update | A Cardinal Health field safety notice clarified adult target population for affected chest drainage units. | Shows continued attention to labeling and patient selection. |
| Training requirement | Manufacturers maintain detailed setup, operation and troubleshooting resources. | Reflects the clinical importance of correct bedside use. |
Source: FDA Atrium; FDA Teleflex; NHS notice; Getinge education.
The market is mature and supplier relationships are important because hospitals standardize chest-drain protocols, accessories and clinical education around selected platforms.
Atrium Oasis and Ocean systems compete through dry or wet suction, visible air-leak monitoring and extensive clinical education.
Pleur-evac offers dry-suction/wet-seal and wet-suction/wet-seal families with multiple chamber configurations.
Other suppliers compete on price, chamber design, regional service and product breadth.
January 2026: A Cardinal Health field safety notice clarified the intended adult patient population for specified chest drainage units and accessories.
2026: Getinge continued commercialization and education for Atrium Oasis dry-suction water-seal chest drains with adjustable suction and visible air-leak monitoring.
2026: Teleflex maintained current Pleur-evac chest drainage system device listings and educational support across multiple chamber and suction configurations.
Current market cycle: Suppliers continue emphasizing easier setup, portability, air-leak visualization and pressure protection rather than major changes to the underlying water-seal principle.
Source: NHS notice; Getinge; FDA Teleflex; Teleflex.
The global water seal chest drainage unit market market is projected to grow from USD 683.7 million in 2026 to USD 939.9 million by 2034, at a 4.1% CAGR during 2026–2034. Growth is expected to remain steady because thoracic drainage is a mature but essential hospital procedure. Incremental value should come from dry suction, portable formats, clearer monitoring and standardized safety features rather than rapid category expansion.
| Forecast Variable | Current Evidence / Starting Point | Expected Effect Through 2034 |
|---|---|---|
| Thoracic surgery | Postoperative drainage creates recurring procedure-linked demand. | Sustains base volume. |
| Dry suction | Mechanical regulation simplifies setup. | Supports product mix shift. |
| Ambulatory care | Portable units improve mobility and selected outpatient management. | Creates growth. |
| Safety features | Pressure relief and visible leak monitoring support premium systems. | Adds value. |
| Asia-Pacific expansion | Hospital and thoracic-care capacity is increasing. | Supports geographic growth. |
The study is structured to support strategy, market-entry assessment, portfolio planning, competitive benchmarking and commercial opportunity analysis across the global water seal chest drainage unit market landscape.
24LifeScience develops water seal chest drainage unit market market estimates using a combination of bottom-up and top-down assessment. Bottom-up work reviews relevant manufacturers, product portfolios, geographic presence, installation or utilization patterns, commercial channels and pricing structure. Top-down work evaluates the addressable testing or diagnostic environment, installed capacity, procedure or production demand, replacement and upgrade cycles, and regional access conditions.
Primary research is used to validate market structure, purchasing criteria, technology adoption, competitive positioning and operating constraints where available. Secondary research prioritizes regulators, government and public-health agencies, recognized standards, peer-reviewed or professional evidence, and company filings or official product communications. The analysis combines the current market scope with FDA device records, Getinge and Teleflex product information, and current safety communications. The displayed 2026 and 2034 values are consistent with a 4.1% CAGR.
Forecasts incorporate the 2025 market base, 2026 estimated conditions, technology and regulatory developments, replacement or expansion demand, regional investment, pricing pressure, service requirements and competitive intensity. High-impact assumptions are cross-checked against authoritative evidence before publication.
The market was valued at USD 657.0 million in 2025 and is estimated at USD 683.7 million in 2026. It is projected to reach USD 939.9 million by 2034 at a 4.1% CAGR during 2026–2034.
It removes air, blood or pleural fluid while preventing atmospheric air from re-entering the pleural space.
Dry-suction systems lead because mechanical suction regulation simplifies setup and reduces dependence on a bubbling water column.
Emergency and postoperative chest drainage generate the largest acute-care demand, while ambulatory use is growing.
North America is the largest regional market because of mature thoracic surgery, trauma and hospital drainage infrastructure.
The water seal acts as a one-way barrier that lets pleural air escape while limiting reverse airflow toward the patient.
Getinge lists fingertip suction adjustment from -10 to -40 cmH - O, preset at -20 cmH - O.
The report profiles Getinge/Atrium, Teleflex/Pleur-evac, Cardinal Health, Redax, Armstrong Medical, Alleva Medical and other regional suppliers.
The standardized forecast period is 2026–2034, with 2025 as the base year and 2026 as the estimated year.
Display logos only where use is approved. A logo does not imply a public endorsement.
The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.
We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.
I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.
Their custom report on clinical trial trends was a helpful reference as we explored new indications.
As someone working on early product planning, I found their therapeutic-area briefs useful and easy to apply in our internal discussions.
We needed dependable data and a clearly presented market structure. The research gave us a practical starting point for our assessment.
Publish named testimonials only when the individual and organization have approved disclosure.
Review the report scope, forecast timeframe, methodology, and cited evidence before deciding whether the full study fits your requirement.
Coverage, segmentation, geography, and market boundaries are stated within the report.
Readers can review the published sources and evidence referenced in this market overview.
Base, estimated, and forecast years are shown to place the market outlook in context.
Each overview displays its report identifier and latest update date.
A structured view of market size, forecast outlook, segmentation, regional dynamics, competitive activity, and the research framework behind this study.
Review the market estimate, growth outlook, forecast direction, and key factors influencing future demand.
Understand the report’s defined segments, demand drivers, applications, end users, and market opportunities.
Assess regional performance, selected country context, and factors shaping adoption across major markets.
Explore company profiles, market positioning, and selected developments relevant to the market landscape.
Review key demand drivers, challenges, emerging opportunities, technology shifts, and factors influencing market direction.
Understand the report scope, market boundaries, research approach, and evidence referenced in the published market overview.